*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on ITRM
    Thinking about buying stock in Akebia Therapeutics, Mind Medicine, ATAI Life Sciences, Doma Holdings, or Iterum Therapeutics?
    9:31a ET April 1 '24 PR Newswire

    InvestorsObserver issues critical PriceWatch Alerts for AKBA, MNMD, ATAI, DOMA, and ITRM.

    https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

    To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

    -- AKBA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AKBA&prnumber=202404012

    -- MNMD: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=MNMD&prnumber=202404012

    -- ATAI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ATAI&prnumber=202404012

    -- DOMA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=DOMA&prnumber=202404012

    -- ITRM: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ITRM&prnumber=202404012

    (Note: You may have to copy this link into your browser then press the [ENTER] key.)

    InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

    InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

    https://c212.net/c/img/favicon.png?sn=CG76423&sd=2024-04-01

    View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-akebia-therapeutics-mind-medicine-atai-life-sciences-doma-holdings-or-iterum-therapeutics-302104450.html

    SOURCE InvestorsObserver

    https://rt.newswire.ca/rt.gif?NewsItemId=CG76423&Transmission_Id=202404010931PR_NEWS_USPR_____CG76423&DateId=20240401

    COMTEX_450175826/1005/2024-04-01T09:31:27

    Thinking about buying stock in Akebia Therapeutics, Mind Medicine, AT...
    9:31a ET April 1 '24 PR Newswire
    Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financi...
    7:00a ET March 28 '24 GlobeNewswire
    Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Finan...
    4:30p ET March 21 '24 GlobeNewswire
    Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home F...
    8:00a ET March 15 '24 GlobeNewswire
    Iterum Therapeutics Provides Business Update
    8:00a ET March 6 '24 GlobeNewswire

    Market data provided by News provided by